Biliary Cancer
📧 Sign up to get email alerts when something new happens for Biliary Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study of Patients Receiving High-Dose Rate Brachytherapy [Phase 2]
A Phase 2 study of high-dose-rate brachytherapy in patients with cervical cancer, endometrial cancer, esophageal cancer, prostate cancer, an…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). [Phase 2]
Phase 2 trial evaluating trametinib plus hydroxychloroquine in KRAS-mutant biliary tract cancers was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Pembrolizumab and GM-CSF in Biliary Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with GM-CSF for biliary cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer [Phase 3]
A Phase 3 trial evaluating TQB2450 with anlotinib as second-line treatment for advanced biliary cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread [Phase 1]
A Phase 1 trial evaluating an IL-2 expressing, attenuated Salmonella Typhimurium for unresectable hepatic spread in liver cancer patients ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]
A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Tremelimumab With Chemoembolization or Ablation for Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tremelimumab combined with chemoembolization or ablation for liver cancers has completed enrollment with results p…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions [Phase 2]
Phase 2 trial evaluating ponatinib hydrochloride in patients with advanced biliary cancer harboring FGFR2 fusions; study completed with post…
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating cisplatin plus irinotecan for biliary cancer (gallbladder or biliary tract cancer). Status is unknown.